Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Here are stocks that brokerage firms recommend for long term. Nomura maintains buy on Maruti with increased target price to Rs 6630 from Rs 5581 per share as its premiumisation strategy is paying off with rich dividends.
Rajat Bose of rajatkbose.com is of the view that one can sell Axis Bank and buy Dr Reddy's Laboratories and Bharat Financial Inclusion.
According to Mitesh Thacker of miteshthacker.com, one can sell HDFc Bank and buy Cipla and Infosys.
Ashwani Gujral of ashwanigujral.com recommends selling Union Bank of India and ICICI Bank and buy Cipla.
Here are 9 stocks that brokerage firms' are bullish on. Morgan Stanley is overweight on Tata Motors with target price of Rs 585 per share. It expects volume to pick-up on XF launch in china & strong new discovery sales.
Here are analysts' views on 11 stocks. Citi says Aurobindo Pharma remains India's top pharma pick as Teva business passes by and key overhang is lifted. It expects focus to shift back to company's robust fundamentals.
Ashwani Gujral of ashwanigujral.com recommends buying Petronet LNG, United Breweries and Cipla.
Ashwani Gujral of ashwanigujral.com advises selling Cipla and Wockhardt.
Sudarshan Sukhani of s2analytics.com suggests buying Apollo Tyres, Reliance Capital and Cipla.
Expressing concern that drug majors are running out of cash in the US market and their generics business is shrinking, Surajit Pal of Prabhudas Lilladher said he doesn‘t expect great returns from large-cap pharma stocks.
In an interview to CNBC-TV18, Prakash Diwan of Altamount Capital Management shared his readings and outlook on specific stocks and sectors.
Here are brokerage firms' views on 16 stocks. Bank of America Merrill Lynch has initiated buy rating with target at Rs 1450 percent indicating 23 percent potential upside. It says Kesh King-led drag behind; upside risk from the global business. The stock is re-rated over time and robust growth to provide support.
Gaurav Bissa of LKP Securities recommends buying Cipla, Reliance Infra and ONGC and advises selling Mindtree.
Rajat Bose of rajatkbose.com is of the view that one can buy Cipla, Wockhardt and Power Grid.
In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy and Anuj Singhal, Rahul Arora, CEO, Nirmal Bang Institutional Equities and Abneesh Roy, Associate Director of Edelweiss Securities shared their readings and outlook Jubilant Foodworks. Rahul Arora also spoke on various stocks.
Mitesh Thacker of miteshthacker.com is of the view that one may sell Reliance Communications and Tata Steel.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Amara Raja Batteries and Divis Lab and sell Indo Count Industries.
According to Ashwani Gujral of ashwanigujral.com, one can buy Amara Raja Batteries, Cipla and Ajanta Pharma.
Rajat Bose of rajatkbose.com is of the view that Aurobindo Pharma may test Rs 814 while Cipla may hit Rs 594.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Delta Corp and Cipla and sell India Cements.
According to VK Sharma, Head Private Broking & Wealth Management at HDFC Securities, one can buy Cipla 600 Call and Cadila Healthcare 300 Call.
Ashwani Gujral of ashwanigujral.com recommends buying Cipla, Rallis India and UCO Bank.
Ashwani Gujral of ashwanigujral.com recommends buying Jain Irrigation , Cipla and UltraTech Cement.
In an interview to Latha Venkatesh and Anuj Singhal on CNBC-TV18, Mehraboon Irani of Nirmal Bang Securities spoke about the current market trends and specific stocks and sectors.
According to Ashwani Gujral of ashwanigujral.com, one can by buy Cipla, Engineers India and Voltas.